» Articles » PMID: 133117

Sex Hormone Binding Globulin: the Carrier Protein for D-norgestrel

Overview
Specialty Endocrinology
Date 1976 Jul 1
PMID 133117
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The binding of different synthetic steroids, used in hormonal contraception, to Sex Hormone Binding Globulin (SHBG) was studied by measuring their ability to displace tritiated testosterone from SHBG in a competitive protein binding system. Only 19-nortestosterone derivates had any significant ability to displace testosterone from SHBG, d-norgestrel (d-Ng) being the strongest displacer. Increasing the SHBG levels in women with previous constant plasma d-Ng levels increased these levels two- to sixfold. It is concluded that SHBG is the main carrier protein for d-Ng. The strong testosterone displacing activity of d-Ng might also explain androgenic side effects observed with d-Ng containig oral contraceptives.

Citing Articles

Levonorgestrel hormone releasing intrauterine system (Mirena) as a contraceptive in egg donors: case report.

Kailasam C, Akande V, Gordon U J Assist Reprod Genet. 2005; 22(3):137-40.

PMID: 16018245 PMC: 3455176. DOI: 10.1007/s10815-005-4889-3.


Levonorgestrel. Clinical pharmacokinetics.

FOTHERBY K Clin Pharmacokinet. 1995; 28(3):203-15.

PMID: 7758251 DOI: 10.2165/00003088-199528030-00003.


Jejunoileal bypass. Long-term results.

ORGAN Jr C, Cegielski M, Grabner B, Keig H, SAPORTA J Ann Surg. 1980; 192(1):38-43.

PMID: 7406562 PMC: 1344803. DOI: 10.1097/00000658-198007000-00007.


The third S.K. & F. Prize lecture, University of London, December 1981. The clinical pharmacology of oral contraceptive steroids.

Orme M Br J Clin Pharmacol. 1982; 14(1):31-42.

PMID: 7049209 PMC: 1427581. DOI: 10.1111/j.1365-2125.1982.tb04931.x.


Binding capacity of testosterone-estradiol-binding globulin (TeBG), total and calculated unbound concentrations of testosterone in patients with carcinoma of the prostate treated with orchidectomy or estrogens.

Damber J, Bergman B, Sodergard R, Tomic R J Endocrinol Invest. 1983; 6(2):91-4.

PMID: 6683289 DOI: 10.1007/BF03350578.